{
    "2018-07-17": [
        [
            {
                "time": "2018-07-17",
                "original_text": "J&J's (JNJ) Q2 Earnings Beat on Higher Cancer Drug Sales",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Q2 Earnings",
                        "Beat",
                        "Higher Cancer Drug Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Mylan signs U.S. license deal on Humira with AbbVie",
                "features": {
                    "keywords": [
                        "Mylan",
                        "U.S. license deal",
                        "Humira",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-19",
                "original_text": "AbbVie Announces HUMIRAÂ® (adalimumab) Patent License with Mylan",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "HUMIRA",
                        "Patent License",
                        "Mylan"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}